Dear investors and netizens
It is a great pleasure to communicate and exchange ideas with everyone today regarding the initial public offering of A-shares by Zhejiang Cheng Yi Pharmaceutical Co., Ltd. On behalf of the company, I would like to express my heartfelt gratitude to the investors and friends from all walks of life who have long cared for and supported the development of the sincere pharmaceutical industry! And express sincere welcome to the friends who participated in today's online communication!
Cheng Yi Pharmaceutical is specialized in the R&D, production and sales of preparations and APIs. Its therapeutic effects range from arthritis, diuresis, sedation and brain tonic, antiviral and anti-tumor, etc. Its main products include Glucosamine hydrochloride APIs and preparations, tolasemide injection and capsules, Gastrodin APIs, Ribavirin and Azathioprine APIs, etc. Among them, Glucosamine hydrochloride APIs and preparations, tolasemide preparations and Gastrodin APIs mainly focus on the domestic market, and Ribavirin and Azathioprine APIs are mainly used for export.
The company adheres to the policy of "quality first, user first", with innovation as the driving force, talent as the foundation, and market orientation, adhering to both internal and external development, accelerating product upgrading and upgrading, and promoting the transformation of product structure from raw materials to formulations; In the future, the company will be built into a drug production base led by marine medicine, biopharmaceuticals, and traditional Chinese medicine.
Today, we sincerely hope that through this online roadshow, investors can have a deeper understanding of the investment value and future development plans of Cheng Yi Pharmaceutical. At the same time, we hope that everyone can speak freely and provide valuable opinions and suggestions. We will also answer and communicate with everyone's concerns in a sincere and responsible manner.
Thank you all!